维普期刊资源整合服务平台（V6.5）

80篇 您的检索式：作者名="MIRIAGOU V"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Panresistance in VIM-1- producing Klebsiella pneumoniae 显示文摘	Miriagou V Tzelepi E Daikos GL etal	2005	J Antimicrob Chemother2005，55，5：	1
2	Acquir-ed carbapenemases in Gram-negative bacterial pa-thogens:detection and surveillance issues显示文摘	Miriagou V Cornaglia G Edelstein M	2010	Clin Microbiol Infect2010，16，2：	1
3	Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2 显示文摘	Miriagou V Tzouvelekis LS Rossiter S	2003	Antimicrob Agents Chemother2003，47，4：	1
4	Antimicrobial suscep- tibility of Neisseria gonorrhoeae in Greece: data for the years 1994-2004 显示文摘	Stathi M Flemetakis A Miriagou V	2006	J Antimierob Chemother2006，57，4：	1
5	Ciprofloxacin-re sistant Escherichia coli in central Greece: mechanisms of resist- ance and molecular identification显示文摘	Mavroidi A Miriagou V Liakopoulos A	2012	BMC Infect Dis2012，12，1：	1
6	Comparative biochemi- cal and computational study of the role of naturally occurring muta- tions at Ambler positions 104 and 170 in GES 13 -lactamases显示文摘	Kotsakis SD Miriagou V Tzelepi E	2010	Antimicrob Agents Chemother2010，54，11：	1
7	Panresistance in VIM-1-producing Klebsiella pneumoniae显示文摘	Miriagou V Tzelepi E Daikos GL		0，，05：	1
8	Relative strength of the class 1 integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active p2 promoter显示文摘	Papagiannitsis CC Tzouvelekis LS Miriagou V		0，，：	1
9	Novel GES/IBC extend- ed - spectrum β- lactamase variants with carbapenemase activity in clinical enterobacteria显示文摘	Vourli S Giakkoupi P Miriagou V	2004	FEMS microbial lett2004，234，2：	1
10	Panresistance in VIM- 1-producing Klebsiella pneumoniae 显示文摘	Miriagou V Tzelepi E Daikos GL	2005	J Antimicrob Chernother2005，55，5：	1
11	Emergence of an inhibitor-resistant β-lactamase (SHV-10)derived from an SHV-5 variant 显示文摘	Prinarakis E E Miriagou V Tzelepi E	1997	Antimicrob Agents and Chemother1997，41，：	1
12	Relative strength of the class I integron promoter hybrid 2 and the combinations of strong and hybrid 1 with an active P2 promoter显示文摘	Papagiannitsis CC Tzouvelekis LS Miriagou V	2009	Antimicrob A- gents Chemother2009，53，1：	1
13	Emergence of an inhibitor-resistant β-lactamase (SHV-10) derived from an SHV-5 variant显示文摘	Prinarakis EE Miriagou V Tzelepi E	1997	Antimicrob Age nts Chemother1997，41，：	1
14	Novel GES/IBC extended-spectrum beta-lactamase variants with carbapenemase activity in clinical enterobacteria显示文摘	Vourli S Giakkoupi P Miriagou V	2004	FEMS Microbiol Lett2004，234，2：	1
15	An ertapenem-resistant extended-spectrum-beta-lacta- mase-producing Klebsiella pneumoniae clone carries a novel OmpK36 porin variant 显示文摘	Gareia-Fernandez A Miriagou V Papagiannitsis C C	2010	Antimierob Agents Chemother2010，54，10：	1
16	Emergence of Escherichia coli sequence type 410 ( ST410 ) with KPC-2 显示文摘	MAVROIDI A MIRIAGOU V MALLI E	2012	Int J AntimicrobAgents2012，39，3：	1
17	Emergence of Escherichia coli sequence type 410(ST410)with KPC-2β-lactamase显示文摘	Mavroidi A Miriagou V Malli E	2012	Int J Antimicrob Agents2012，39，3：	1
18	Emergence of an inhibitor-resistant beta-lactamase (SHV-10) derived from an SHV-5 variant 显示文摘	Prinarakis E E Miriagou V Tzelepi E	1997	Antimicrob Agents Chemother1997，41，4：	1
19	Imipenem resistant in a Salmonella clinical strain due to plasmid-mediated class A carbap- enemase KPC-2 显示文摘	Miriagou V Tzouvelekis L S Rossiter S	2003	Antimicrob Agents Chemother2003，47，4：	1
20	An updateof the evolving epidemic of blaKPC-2-carrying Klebsiellapneumoniae in Greece(2009-10)显示文摘	Giakkoupi P Papagiannitsis CC Miriagou V	2011	J Antimicrob Chemoth-er2011，66，7：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示